Publications

AI-driven discovery and validation of a GIPC1 PDZ domain inhibitor for pancreatic ductal adenocarcinoma

 4
AI-driven discovery and validation of a GIPC1 PDZ domain inhibitor for pancreatic ductal adenocarcinoma

Tags:

Previous Article

Somatic mutations reveal the ontogeny of human microglia

Next Article

AI designed small molecule inhibitor against pancreatic cancer

Related Posts

Repetitive neuronal activation regulates cellular maturation state via nuclear reprogramming

Repetitive neuronal activation regulates cellular matur...

 29

Pharmacologic reversal of advanced Alzheimer’s disease in mice and identification of potential therapeutic nodes in human brain

Pharmacologic reversal of advanced Alzheimer’s disease ...

 50

Diverse anti-defence systems are encoded in the leading region of plasmids

Diverse anti-defence systems are encoded in the leading...

 133